Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PIK3R5-DT is a divergent transcript (non-coding RNA) located adjacent to the PIK3R5 gene, which encodes phosphoinositide-3-kinase regulatory subunit 5, a protein involved in class IB PI3K signaling—important in cell growth, proliferation, differentiation, motility, and survival[1][3][9]. PIK3R5-DT itself is not characterized as a protein-coding gene and lacks experimental evidence for direct biological function or clinical relevance. Most available data and disease associations pertain to the protein-coding PIK3R5 gene, not the divergent transcript. Synonyms such as CTB-41I6.1 and CTB-41I6.2 denote alternate transcript names with limited functional annotation[5]. If you seek information on therapeutic targets, the functionally relevant entity is the Phosphoinositide-3-kinase regulatory subunit 5 (PIK3R5), not the divergent transcript. PIK3R5 (protein) is implicated in oncogenesis and other pathophysiological processes, but PIK3R5-DT does not currently have sufficient evidence to be considered a molecular target for therapy or drug development[1][3][9]. The distinction between PIK3R5-DT (RNA, non-coding transcript) and PIK3R5 (protein-coding) is critical. PIK3R5-DT has not been established as a biological target, and information is limited to transcript annotation databases[5]. This term should be used with caution if your aim is to reference therapeutic targets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PIK3R5 divergent transcript (PIK3R5-DT).